文献
J-GLOBAL ID:202202246889680142
整理番号:22A0177021
SOX9により仲介されるエンハンサー駆動幹細胞様プログラムは結腸直腸癌における腸分化を阻害する【JST・京大機械翻訳】
An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer
著者 (28件):
Liang Xiaoyan
(Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China)
,
Liang Xiaoyan
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Duronio Gina N.
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Yang Yaying
(Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, China)
,
Bala Pratyusha
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Hebbar Prajna
(Department of Information Technology, National Institute of Technology Karnataka, Surathkal, India)
,
Spisak Sandor
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Spisak Sandor
(Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Sahgal Pranshu
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Sahgal Pranshu
(Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts)
,
Singh Harshabad
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Singh Harshabad
(Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Singh Harshabad
(Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts)
,
Zhang Yanxi
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Xie Yingtian
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Xie Yingtian
(Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Cejas Paloma
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Cejas Paloma
(Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Long Henry W.
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Long Henry W.
(Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Bass Adam J.
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Bass Adam J.
(Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts)
,
Bass Adam J.
(Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Bass Adam J.
(Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts)
,
Sethi Nilay S.
(Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Sethi Nilay S.
(Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts)
,
Sethi Nilay S.
(Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Sethi Nilay S.
(Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts)
資料名:
Gastroenterology
(Gastroenterology)
巻:
162
号:
1
ページ:
209-222
発行年:
2022年
JST資料番号:
H0767A
ISSN:
0016-5085
CODEN:
GASTAB
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)